Tarvos Capital Management is an independent, research-centric, investment management and advisory firm focused mostly on publicly traded and private equities in growth sectors of the medical technology, biotechnology and healthcare services industries.     Our investment focus emphasizes companies offering unique platforms or special situations that provide above-average, long-term total returns. We maintain a fundamental research orientation with a strong valuation discipline.  Since 2006, Tarvos Capital Management has shared an exclusive research and advisory agreement with Bellevue Asset Management of Zurich, Switzerland.